1Pederson JR,Olsson AG,Faergeman V,et al.Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)[].Circulation.1998
2Flaker GC,Warnica JW,Sacks FM,et al.For the Cholesterol and Recurrent Event ( CARE) investigators.Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations[].Journal of the American College of Cardiology.1999
3Dupuis J,Tardif JC,Cernack P,et al.Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: the RECIFE trial[].Circulation.1999
4Dupuis J,Tardif JC,Cernacek P,et al.cholesterol reduction rapidly improves endothelial function after acute coronary syndromes.The RECIFE trial[].Circulation.1999
5Corti R,Fayad ZA,Fuster V,et al.Effects of lipid-lowering by simvastatin on human ahterosclerotic lesions[].Circulation.2001
6Sacks FM.Lipid-lowering therapy in acute coronary syndromes[].The Journal of The American Medical Association.2001
7Williams JK,Sukhova GK,Herrington DM,et al.Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys[].Journal of the American College of Cardiology.1998
8Crisby M,Nordin FG,Shah PK,et al.Pravastatin treament increases collagen content and decreases lipid content, inflammation,metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization[].Circulation.2001
9Rauch U,Osende JI,Chesebro JH,et al.Statin and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins[].Atherosclerosis.2000
10Libby P.Current concepts of the pathogenesis of the acute coronary syndromes[].Circulation.2001
